Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Detection of Pneumonia Pathogens from Plasma Cell-Free DNA

PROVIDER: PRJNA525157 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8663630_1.fastq.gz	Fastqsanger.gz
	SRR8663630_2.fastq.gz	Fastqsanger.gz
	SRR8663640_1.fastq.gz	Fastqsanger.gz
	SRR8663640_2.fastq.gz	Fastqsanger.gz
	SRR8663650_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Homo sapiens

Project description:Seminal Plasma cell-free DNA

| PRJNA1162531 | ENA

Project description:Plasma Cell-Free DNA Metagenomic Next-Generation Sequencing for Diagnosis of Severe Pneumonia

| PRJNA783497 | ENA

Integrated host-microbe metagenomics of cell-free nucleic acid for sepsis diagnosis in critically ill adults [plasma]

Project description:Here we developed a new approach to sepsis diagnosis that integrates host transcriptional profiling with metagenomic broad-range pathogen detection from cell-free plasma RNA and DNA.

2022-08-03 | GSE189401 | GEO

Integrated host-microbe metagenomics of cell-free nucleic acid for sepsis diagnosis in critically ill adults [paxgene]

2022-08-03 | GSE189400 | GEO

Project description:cell-free DNA sequencing of plasma

| PRJNA687910 | ENA

Homo sapiens

Project description:non-invasive detection of fetal aneuploidy from cell-free DNA (plasma pregnant women)

| PRJNA30977 | ENA

Circulation cell-free DNA as a biomarker applied in clinical practice of gastrointestinal tumor

Project description:Interventions: Gold Standard:;Index test: Primary outcome(s): concentration of cell-free DNA in plasma;integrity of cell-free DNA in plasma Study Design: Diagnostic test: case-control

| 2662278 | ecrin-mdr-crc

Blood borne pathogen detection in blood and plasma by Microarray

Project description:The Blood Borne Pathogen Resequencing Microarray Expanded (BBP-RMAv.2) is a platform that allows multiplex detection and identification of 80 different blood-borne pathogens in one single test, comprising 60 virus, 5 bacteria and 15 parasites. The objective is to evaluate the lowest concentration detected in blood or plasma, species discrimination and applicability of the microarray platform for testing blood donors. Human blood or plasma spiked with selected pathogens (10,000, 1,000 or 100 cells or copies/ml), including 6 viral, 2 bacterial and 5 protozoan pathogens were each tested on this platform. The nucleic acids were extracted, amplified using multiplexed sets of pooled specific primers, fragmented, labeled, and hybridized to a microarray. Finally, the detected sequences were identified using an automated genomic database alignment algorithm. The performance of the BBP-RMAv.2 demonstrated detection for most spiked protozoan pathogens at 1,000 cells/ml, 10,000 cells/ml for bacterial pathogens and as low as 100 copies/ml for viral pathogens. Coded specimens, including spiked and negative controls, were identified correctly for one blood specimen and for two plasma specimens. One negative plasma resulted in a false positive detection of a virus demonstrating the effectiveness of the platform.

2024-06-08 | E-MTAB-13972 | biostudies-arrayexpress

Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA

Project description:Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA

| PRJEB3952 | ENA

Cell-free DNA 5-hydroxymethylcytosine as a marker for common cancer detection

Project description:We used a highly sensitive nano-5hmC-Seal method and profiled the genome-wide distribution of 5-hydroxymethylcytosine (5hmC) in plasma cell-free DNA (cfDNA) from 384 patients with bladder, breast, colorectal, kidney, lung, or prostate cancer and 221 controls. We used machine learning and developed plasma cfDNA 5hmC signatures that are highly sensitive for cancer detection and cancer origin determination. We also identified genes and signaling pathways with aberrant DNA hydroxymethylation in six cancers.

2022-09-23 | GSE202988 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data